Sanius Health is excited about the recent developments from the NHS regarding better access for patients to their medical records, alongside the Health Secretary’s vision for patients to take greater control of their health journeys through wearable technology.
The company is proud to have been pioneers in this space, particularly in blood cancers, rare diseases, and its flagship area of Sickle Cell Anaemia.
With over 3.5 million and 15 million people in the UK estimated to be living with a rare disease or chronic condition, respectively, which costs the NHS approximately £3.4 billion and £20.5 billion annually, this presents an opportunity for the company to work closely with the NHS to scale the successes it has already had in improving outcomes for patients and their families.
Through its use of .
